FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Emergency Use Authorization Given to 4 Zika Tests

[ Price : $8.95]

Federal Register Notice: FDA announces the issuance of Emergency Use Authorizations for four in vitro diagnostic devices for detec...

FDA Complete Response on Sanofi/Regenerons Arthritis Therapy

[ Price : $8.95]

FDA sends Regeneron Pharmaceuticals and Sanofi a Complete Response Letter on their BLA for sarilumab, an investigational interleuk...

HeartWare Recalls Ventricular Assist Device

[ Price : $8.95]

HeartWare Inc. begins a Class 1 recall of its Ventricular Assist Device controller due to a loose power connector which may cause ...

FDA Approves Roche Assay for New Lung Cancer Therapy

[ Price : $8.95]

FDA approves a Roche PMA for the Ventana PD-L1 (SP142) Assay as a complementary diagnostic to identify PD-L1 expression levels in ...

Adamas Pharmaceuticals Files NDA for Parkinsons Therapy

[ Price : $8.95]

Adamas Pharmaceuticals files an NDA for ADS-5102 (amantadine hydrochloride) extended-release capsules, indicated for treating levo...

FDA Clears SeaSpines Anterior Cervical System

[ Price : $8.95]

FDA clears a SeaSpine Holdings 510(k) for its Shoreline ACS Anterior Cervical Standalone System, which features TruProfile technol...

Salix Wants Restrictions on Xifaxan ANDAs

[ Price : $8.95]

Salix asks FDA to require several specific test results for any ANDA citing any strength or indication of Xifaxan as the reference...

GDUFA Regulatory Science Priorities

[ Price : $8.95]

FDA publishes generic drug regulatory science priorities for FY 2017.

FDA Awards Engility $112 Million Computational Science Contract

[ Price : $8.95]

FDA awards Engility Holdings a $112 million five-year contract for computational science and bioinformatics services.

Legislative MDUFA 4 Changes

[ Price : $8.95]

A summary of draft legislation shows funding changes under the MDUFA 4 agreement.